1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope
2. Executive Summary
2.1. Market Snapshot: Global Human Insulin Market
2.2. Global Human Insulin Market, By Product Type
2.3. Global Human Insulin Market, By Drugs
2.4. Global Human Insulin Market, By Delivery Devices
2.5. Global Human Insulin Market, By Brand
2.6. Global Human Insulin Market, By Region
3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Human Insulin Market Value, 2017-2030, (US$ Bn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.2. Market Restraints
3.2.3. Market Opportunities
3.2.4. Major Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Product Type
3.5.2. Drugs
3.5.3. Delivery Devices
3.5.4. Brand
3.5.5. Geography
4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Technology Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. Indirect Marketing
4.7.3. Marketing Channel Development Trend
5. Market Positioning of Key Players, 2022
5.1. Company Market Share of Key Players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others
6. Economic Impact Analysis
6.1. Recession Impact
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Latin America
6.1.5. Middle East and Africa
6.2. Ukraine-Russia War Impact
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East and Africa
6.3. COVID-19 Impact Analysis
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. Latin America
6.3.5. Middle East and Africa
7. Global Human Insulin Market
7.1. Global Human Insulin Market, by Product Type, 2017-2030(US$ Bn)
7.1.1. Overview
7.1.2. Global Human Insulin Market, By Product Type, 2022 vs 2030 (in%)
7.1.3. Global Human Insulin Market, By Drugs, 2017-2030 (US$ Bn)
7.1.4. Global Human Insulin Market, By Delivery Devices, 2017-2030 (US$ Bn)
7.2. Global Human Insulin Market, by Drugs, 2017-2030(US$ Bn)
7.2.1. Overview
7.2.2. Global Human Insulin Market, By Drugs, 2022 vs 2030 (in%)
7.2.3. Global Human Insulin Market, By Insulin Analogs & Biosimilars, 2017-2030 (US$ Bn)
7.2.4. Global Human Insulin Market, By Human Insulin Biologics, 2017-2030 (US$ Bn)
7.3. Global Human Insulin Market, by Delivery Devices, 2017-2030(US$ Bn)
7.3.1. Overview
7.3.2. Global Human Insulin Market, By Delivery Devices, 2022 vs 2030 (in%)
7.3.3. Global Human Insulin Market, By Pens, 2017-2030 (US$ Bn)
7.3.4. Global Human Insulin Market, By Pen Needles, 2017-2030 (US$ Bn)
7.3.5. Global Human Insulin Market, By Syringes, 2017-2030 (US$ Bn)
7.3.6. Global Human Insulin Market, By Others, 2017-2030 (US$ Bn)
7.4. Global Human Insulin Market, by Brand, 2017-2030(US$ Bn)
7.4.1. Overview
7.4.2. Global Human Insulin Market, By Brand, 2022 vs 2030 (in%)
7.4.3. Global Human Insulin Market, By Humulin, 2017-2030 (US$ Bn)
7.4.4. Global Human Insulin Market, By Insuman, 2017-2030 (US$ Bn)
7.4.5. Global Human Insulin Market, By Lantus, 2017-2030 (US$ Bn)
7.4.6. Global Human Insulin Market, By Novorapid & Novolog, 2017-2030 (US$ Bn)
7.4.7. Global Human Insulin Market, By Humalog, 2017-2030 (US$ Bn)
7.4.8. Global Human Insulin Market, By Others, 2017-2030 (US$ Bn)
8. North America Human Insulin Market Analysis
8.1. North America Human Insulin Market, by Product Type, 2017-2030(US$ Bn)
8.1.1. Overview
8.1.2. SRC Analysis
8.2. North America Human Insulin Market, by Drugs, 2017-2030(US$ Bn)
8.2.1. Overview
8.2.2. SRC Analysis
8.3. North America Human Insulin Market, by Delivery Devices, 2017-2030(US$ Bn)
8.3.1. Overview
8.3.2. SRC Analysis
8.4. North America Human Insulin Market, by Brand, 2017-2030(US$ Bn)
8.4.1. Overview
8.4.2. SRC Analysis
8.5. North America Human Insulin Market, by Country, 2017-2030 (US$ Bn)
8.5.1. U.S.
8.5.1.1. U.S. Human Insulin Market Estimates and Forecast, 2017-2030 (US$ Bn)
8.5.1.2. U.S. Human Insulin, By Product Type, 2017-2030 (US$ Bn)
8.5.1.3. U.S. Human Insulin, By Drugs, 2017-2030 (US$ Bn)
8.5.1.4. U.S. Human Insulin, By Delivery Devices, 2017-2030 (US$ Bn)
8.5.1.5. U.S. Human Insulin, By Brand, 2017-2030 (US$ Bn)
8.5.2. Canada
8.5.2.1. Canada Human Insulin Market Estimates and Forecast, 2017-2030 (US$ Bn)
8.5.2.2. Canada Human Insulin, By Product Type, 2017-2030 (US$ Bn)
8.5.2.3. Canada Human Insulin, By Drugs, 2017-2030 (US$ Bn)
8.5.2.4. Canada Human Insulin, By Delivery Devices, 2017-2030 (US$ Bn)
8.5.2.5. Canada Human Insulin, By Brand, 2017-2030 (US$ Bn)
9. Europe Human Insulin Market Analysis
9.1. Europe Human Insulin Market, by Product Type, 2017-2030(US$ Bn)
9.1.1. Overview
9.1.2. SRC Analysis
9.2. Europe Human Insulin Market, by Drugs, 2017-2030(US$ Bn)
9.2.1. Overview
9.2.2. SRC Analysis
9.3. Europe Human Insulin Market, by Delivery Devices, 2017-2030(US$ Bn)
9.3.1. Overview
9.3.2. SRC Analysis
9.4. Europe Human Insulin Market, by Brand, 2017-2030(US$ Bn)
9.4.1. Overview
9.4.2. SRC Analysis
9.5. Europe Human Insulin Market, by Country, 2017-2030 (US$ Bn)
9.5.1. Germany
9.5.1.1. Germany Human Insulin Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.5.1.2. Germany Human Insulin, By Product Type, 2017-2030 (US$ Bn)
9.5.1.3. Germany Human Insulin, By Drugs, 2017-2030 (US$ Bn)
9.5.1.4. Germany Human Insulin, By Delivery Devices, 2017-2030 (US$ Bn)
9.5.1.5. Germany Human Insulin, By Brand, 2017-2030 (US$ Bn)
9.5.2. France
9.5.2.1. France Human Insulin Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.5.2.2. France Human Insulin, By Product Type, 2017-2030 (US$ Bn)
9.5.2.3. France Human Insulin, By Drugs, 2017-2030 (US$ Bn)
9.5.2.4. France Human Insulin, By Delivery Devices, 2017-2030 (US$ Bn)
9.5.2.5. France Human Insulin, By Brand, 2017-2030 (US$ Bn)
9.5.3. UK
9.5.3.1. UK Human Insulin Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.5.3.2. UK Human Insulin, By Product Type, 2017-2030 (US$ Bn)
9.5.3.3. UK Human Insulin, By Drugs, 2017-2030 (US$ Bn)
9.5.3.4. UK Human Insulin, By Delivery Devices, 2017-2030 (US$ Bn)
9.5.3.5. UK Human Insulin, By Brand, 2017-2030 (US$ Bn)
9.5.4. Italy
9.5.4.1. Italy Human Insulin Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.5.4.2. Italy Human Insulin, By Product Type, 2017-2030 (US$ Bn)
9.5.4.3. Italy Human Insulin, By Drugs, 2017-2030 (US$ Bn)
9.5.4.4. Italy Human Insulin, By Delivery Devices, 2017-2030 (US$ Bn)
9.5.4.5. Italy Human Insulin, By Brand, 2017-2030 (US$ Bn)
9.5.5. Spain
9.5.5.1. Spain Human Insulin Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.5.5.2. Spain Human Insulin, By Product Type, 2017-2030 (US$ Bn)
9.5.5.3. Spain Human Insulin, By Drugs, 2017-2030 (US$ Bn)
9.5.5.4. Spain Human Insulin, By Delivery Devices, 2017-2030 (US$ Bn)
9.5.5.5. Spain Human Insulin, By Brand, 2017-2030 (US$ Bn)
9.5.6. Rest of Europe
9.5.6.1. Rest of Europe Human Insulin Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.5.6.2. Rest of Europe Human Insulin, By Product Type, 2017-2030 (US$ Bn)
9.5.6.3. Rest of Europe Human Insulin, By Drugs, 2017-2030 (US$ Bn)
9.5.6.4. Rest of Europe Human Insulin, By Delivery Devices, 2017-2030 (US$ Bn)
9.5.6.5. Rest of Europe Human Insulin, By Brand, 2017-2030 (US$ Bn)
10. Asia Pacific Human Insulin Market Analysis
10.1. Asia Pacific Human Insulin Market, by Product Type, 2017-2030(US$ Bn)
10.1.1. Overview
10.1.2. SRC Analysis
10.2. Asia Pacific Human Insulin Market, by Drugs, 2017-2030(US$ Bn)
10.2.1. Overview
10.2.2. SRC Analysis
10.3. Asia Pacific Human Insulin Market, by Delivery Devices, 2017-2030(US$ Bn)
10.3.1. Overview
10.3.2. SRC Analysis
10.4. Asia Pacific Human Insulin Market, by Brand, 2017-2030(US$ Bn)
10.4.1. Overview
10.4.2. SRC Analysis
10.5. Asia Pacific Human Insulin Market, by Country, 2017-2030 (US$ Bn)
10.5.1. China
10.5.1.1. China Human Insulin Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.5.1.2. China Human Insulin, By Product Type, 2017-2030 (US$ Bn)
10.5.1.3. China Human Insulin, By Drugs, 2017-2030 (US$ Bn)
10.5.1.4. China Human Insulin, By Delivery Devices, 2017-2030 (US$ Bn)
10.5.1.5. China Human Insulin, By Brand, 2017-2030 (US$ Bn)
10.5.2. Japan
10.5.2.1. Japan Human Insulin Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.5.2.2. Japan Human Insulin, By Product Type, 2017-2030 (US$ Bn)
10.5.2.3. Japan Human Insulin, By Drugs, 2017-2030 (US$ Bn)
10.5.2.4. Japan Human Insulin, By Delivery Devices, 2017-2030 (US$ Bn)
10.5.2.5. Japan Human Insulin, By Brand, 2017-2030 (US$ Bn)
10.5.3. India
10.5.3.1. India Human Insulin Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.5.3.2. India Human Insulin, By Product Type, 2017-2030 (US$ Bn)
10.5.3.3. India Human Insulin, By Drugs, 2017-2030 (US$ Bn)
10.5.3.4. India Human Insulin, By Delivery Devices, 2017-2030 (US$ Bn)
10.5.3.5. India Human Insulin, By Brand, 2017-2030 (US$ Bn)
10.5.4. South Korea
10.5.4.1. South Korea Human Insulin Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.5.4.2. South Korea Human Insulin, By Product Type, 2017-2030 (US$ Bn)
10.5.4.3. South Korea Human Insulin, By Drugs, 2017-2030 (US$ Bn)
10.5.4.4. South Korea Human Insulin, By Delivery Devices, 2017-2030 (US$ Bn)
10.5.4.5. South Korea Human Insulin, By Brand, 2017-2030 (US$ Bn)
10.5.5. South-East Asia
10.5.5.1. South-East Asia Human Insulin Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.5.5.2. South-East Asia Human Insulin, By Product Type, 2017-2030 (US$ Bn)
10.5.5.3. South-East Asia Human Insulin, By Drugs, 2017-2030 (US$ Bn)
10.5.5.4. South-East Asia Human Insulin, By Delivery Devices, 2017-2030 (US$ Bn)
10.5.5.5. South-East Asia Human Insulin, By Brand, 2017-2030 (US$ Bn)
10.5.6. Rest of Asia Pacific
10.5.6.1. Rest of Asia Pacific Human Insulin Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.5.6.2. Rest of Asia Pacific Human Insulin, By Product Type, 2017-2030 (US$ Bn)
10.5.6.3. Rest of Asia Pacific Human Insulin, By Drugs, 2017-2030 (US$ Bn)
10.5.6.4. Rest of Asia Pacific Human Insulin, By Delivery Devices, 2017-2030 (US$ Bn)
10.5.6.5. Rest of Asia Pacific Human Insulin, By Brand, 2017-2030 (US$ Bn)
11. Latin America Human Insulin Market Analysis
11.1. Latin America Human Insulin Market, by Product Type, 2017-2030(US$ Bn)
11.1.1. Overview
11.1.2. SRC Analysis
11.2. Latin America Human Insulin Market, by Drugs, 2017-2030(US$ Bn)
11.2.1. Overview
11.2.2. SRC Analysis
11.3. Latin America Human Insulin Market, by Delivery Devices, 2017-2030(US$ Bn)
11.3.1. Overview
11.3.2. SRC Analysis
11.4. Latin America Human Insulin Market, by Brand, 2017-2030(US$ Bn)
11.4.1. Overview
11.4.2. SRC Analysis
11.5. Latin America Human Insulin Market, by Country, 2017-2030 (US$ Bn)
11.5.1. Brazil
11.5.1.1. Brazil Human Insulin Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.5.1.2. Brazil Human Insulin, By Product Type, 2017-2030 (US$ Bn)
11.5.1.3. Brazil Human Insulin, By Drugs, 2017-2030 (US$ Bn)
11.5.1.4. Brazil Human Insulin, By Delivery Devices, 2017-2030 (US$ Bn)
11.5.1.5. Brazil Human Insulin, By Brand, 2017-2030 (US$ Bn)
11.5.2. Mexico
11.5.2.1. Mexico Human Insulin Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.5.2.2. Mexico Human Insulin, By Product Type, 2017-2030 (US$ Bn)
11.5.2.3. Mexico Human Insulin, By Drugs, 2017-2030 (US$ Bn)
11.5.2.4. Mexico Human Insulin, By Delivery Devices, 2017-2030 (US$ Bn)
11.5.2.5. Mexico Human Insulin, By Brand, 2017-2030 (US$ Bn)
11.5.3. Rest of Latin America
11.5.3.1. Rest of Latin America Human Insulin Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.5.3.2. Rest of Latin America Human Insulin, By Product Type, 2017-2030 (US$ Bn)
11.5.3.3. Rest of Latin America Human Insulin, By Drugs, 2017-2030 (US$ Bn)
11.5.3.4. Rest of Latin America Human Insulin, By Delivery Devices, 2017-2030 (US$ Bn)
11.5.3.5. Rest of Latin America Human Insulin, By Brand, 2017-2030 (US$ Bn)
12. Middle East and Africa Human Insulin Market Analysis
12.1. Middle East and Africa Human Insulin Market, by Product Type, 2017-2030(US$ Bn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. Middle East and Africa Human Insulin Market, by Drugs, 2017-2030(US$ Bn)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. Middle East and Africa Human Insulin Market, by Delivery Devices, 2017-2030(US$ Bn)
12.3.1. Overview
12.3.2. SRC Analysis
12.4. Middle East and Africa Human Insulin Market, by Brand, 2017-2030(US$ Bn)
12.4.1. Overview
12.4.2. SRC Analysis
12.5. Middle East and Africa Human Insulin Market, by Country, 2017-2030 (US$ Bn)
12.5.1. GCC Countries
12.5.1.1. GCC Countries Human Insulin Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.5.1.2. GCC Countries Human Insulin, By Product Type, 2017-2030 (US$ Bn)
12.5.1.3. GCC Countries Human Insulin, By Drugs, 2017-2030 (US$ Bn)
12.5.1.4. GCC Countries Human Insulin, By Delivery Devices, 2017-2030 (US$ Bn)
12.5.1.5. GCC Countries Human Insulin, By Brand, 2017-2030 (US$ Bn)
12.5.2. South Africa
12.5.2.1. South Africa Human Insulin Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.5.2.2. South Africa Human Insulin, By Product Type, 2017-2030 (US$ Bn)
12.5.2.3. South Africa Human Insulin, By Drugs, 2017-2030 (US$ Bn)
12.5.2.4. South Africa Human Insulin, By Delivery Devices, 2017-2030 (US$ Bn)
12.5.2.5. South Africa Human Insulin, By Brand, 2017-2030 (US$ Bn)
12.5.3. Rest of Middle East and Africa
12.5.3.1. Rest of Middle East and Africa Human Insulin Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.5.3.2. Rest of Middle East and Africa Human Insulin, By Product Type, 2017-2030 (US$ Bn)
12.5.3.3. Rest of Middle East and Africa Human Insulin, By Drugs, 2017-2030 (US$ Bn)
12.5.3.4. Rest of Middle East and Africa Human Insulin, By Delivery Devices, 2017-2030 (US$ Bn)
12.5.3.5. Rest of Middle East and Africa Human Insulin, By Brand, 2017-2030 (US$ Bn)
13. Company Profiles
13.1. Novo Nordisk A/S (Denmark)
13.1.1. Company Overview
13.1.2. Products/Services Portfolio
13.1.3. Geographical Presence
13.1.4. Financial Summary
13.1.4.1. Market Revenue and Net Profit (2019-2022)
13.1.4.2. Business Segment Revenue Analysis
13.1.4.3. Geographical Revenue Analysis
13.2. Eli Lilly & Company (US)
13.3. Boston Scientific Corporation (US)
13.4. Sanofi (France)
13.5. Boehringer Ingelheim International GmbH (Germany)
13.6. Biocon (India)
13.7. Tonghua Dongbao Pharmaceutical (China)
13.8. Julphar (UAE)
13.9. Wockhardt (India)
13.10. Others
List of Figures
FIG. 1 Global Human Insulin Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Human Insulin Market Segmentation
FIG. 4 Global Human Insulin Market, by Product Type, 2022 (US$ Bn)
FIG. 5 Global Human Insulin Market, by Drugs, 2022 (US$ Bn)
FIG. 6 Global Human Insulin Market, by Delivery Devices, 2022 (US$ Bn)
FIG. 7 Global Human Insulin Market, by Brand, 2022 (US$ Bn)
FIG. 8 Global Human Insulin Market, by Geography, 2022 (US$ Bn)
FIG. 9 Attractive Investment Proposition, by Product Type, 2022
FIG. 10 Attractive Investment Proposition, by Drugs, 2022
FIG. 11 Attractive Investment Proposition, by Delivery Devices, 2022
FIG. 12 Attractive Investment Proposition, by Brand, 2022
FIG. 13 Attractive Investment Proposition, by Geography, 2022
FIG. 14 Global Market Share Analysis of Key Human Insulin Market Manufacturers, 2022
FIG. 15 Global Market Positioning of Key Human Insulin Market Manufacturers, 2022
FIG. 16 Global Human Insulin Market Value Contribution, By Product Type, 2022 & 2030 (Value %)
FIG. 17 Global Human Insulin Market, by Drugs, Value, 2017-2030 (US$ Bn)
FIG. 18 Global Human Insulin Market, by Delivery Devices, Value, 2017-2030 (US$ Bn)
FIG. 19 Global Human Insulin Market Value Contribution, By Drugs, 2022 & 2030 (Value %)
FIG. 20 Global Human Insulin Market, by Insulin Analogs & Biosimilars, Value, 2017-2030 (US$ Bn)
FIG. 21 Global Human Insulin Market, by Human Insulin Biologics, Value, 2017-2030 (US$ Bn)
FIG. 22 Global Human Insulin Market Value Contribution, By Delivery Devices, 2022 & 2030 (Value %)
FIG. 23 Global Human Insulin Market, by Pens, Value, 2017-2030 (US$ Bn)
FIG. 24 Global Human Insulin Market, by Pen Needles, Value, 2017-2030 (US$ Bn)
FIG. 25 Global Human Insulin Market, by Syringes, Value, 2017-2030 (US$ Bn)
FIG. 26 Global Human Insulin Market, by Others, Value, 2017-2030 (US$ Bn)
FIG. 27 Global Human Insulin Market Value Contribution, By Brand, 2022 & 2030 (Value %)
FIG. 28 Global Human Insulin Market, by Humulin, Value, 2017-2030 (US$ Bn)
FIG. 29 Global Human Insulin Market, by Insuman, Value, 2017-2030 (US$ Bn)
FIG. 30 Global Human Insulin Market, by Lantus, Value, 2017-2030 (US$ Bn)
FIG. 31 Global Human Insulin Market, by Novorapid & Novolog, Value, 2017-2030 (US$ Bn)
FIG. 32 Global Human Insulin Market, by Humalog, Value, 2017-2030 (US$ Bn)
FIG. 33 Global Human Insulin Market, by Others, Value, 2017-2030 (US$ Bn)
FIG. 34 U.S. Human Insulin Market, 2017-2030 (US$ Bn)
FIG. 35 Canada Human Insulin Market, 2017-2030 (US$ Bn)
FIG. 36 Germany Human Insulin Market, 2017-2030 (US$ Bn)
FIG. 37 France Human Insulin Market, 2017-2030 (US$ Bn)
FIG. 38 U.K. Human Insulin Market, 2017-2030 (US$ Bn)
FIG. 39 Italy Human Insulin Market, 2017-2030 (US$ Bn)
FIG. 40 Spain Human Insulin Market, 2017-2030 (US$ Bn)
FIG. 41 Rest of Europe Human Insulin Market, 2017-2030 (US$ Bn)
FIG. 42 China Human Insulin Market, 2017-2030 (US$ Bn)
FIG. 43 Japan Human Insulin Market, 2017-2030 (US$ Bn)
FIG. 44 India Human Insulin Market, 2017-2030 (US$ Bn)
FIG. 45 South Korea Human Insulin Market, 2017-2030 (US$ Bn)
FIG. 46 Southeast Asia Human Insulin Market, 2017-2030 (US$ Bn)
FIG. 47 Rest of Asia Pacific Human Insulin Market, 2017-2030 (US$ Bn)
FIG. 48 Latin America Human Insulin Market, 2017-2030 (US$ Bn)
FIG. 49 Brazil Human Insulin Market, 2017-2030 (US$ Bn)
FIG. 50 Mexico Human Insulin Market, 2017-2030 (US$ Bn)
FIG. 51 Rest of Latin America Human Insulin Market, 2017-2030 (US$ Bn)
FIG. 52 Middle East & Africa Human Insulin Market, 2017-2030 (US$ Bn)
FIG. 53 GCC Countries Human Insulin Market, 2017-2030 (US$ Bn)
FIG. 54 South Africa Human Insulin Market, 2017-2030 (US$ Bn)
FIG. 55 Rest of Middle East and Africa Human Insulin Market, 2017-2030 (US$ Bn)
List of Tables
TABLE 1 Market Snapshot: Global Human Insulin Market
TABLE 2 Global Human Insulin Market, by Competitive Benchmarking, 2022
TABLE 3 Global Human Insulin Market, by Geographical Presence Analysis, 2022
TABLE 4 Global Human Insulin Market, by Key Strategies Analysis, 2022
TABLE 5 Global Human Insulin Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 6 Global Human Insulin Market, by Drugs, 2017-2030 (US$ Bn)
TABLE 7 Global Human Insulin Market, by Delivery Devices, 2017-2030 (US$ Bn)
TABLE 8 Global Human Insulin Market, by Brand, 2017-2030 (US$ Bn)
TABLE 9 Global Human Insulin Market, by Geography, 2017-2030 (US$ Bn)
TABLE 10 North America Human Insulin Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 11 North America Human Insulin Market, by Drugs, 2017-2030 (US$ Bn)
TABLE 12 North America Human Insulin Market, by Delivery Devices, 2017-2030 (US$ Bn)
TABLE 13 North America Human Insulin Market, by Brand, 2017-2030 (US$ Bn)
TABLE 14 North America Human Insulin Market, by Country, 2017-2030 (US$ Bn)
TABLE 15 US Human Insulin Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 16 US Human Insulin Market, by Drugs, 2017-2030 (US$ Bn)
TABLE 17 US Human Insulin Market, by Delivery Devices, 2017-2030 (US$ Bn)
TABLE 18 US Human Insulin Market, by Brand, 2017-2030 (US$ Bn)
TABLE 19 Canada Human Insulin Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 20 Canada Human Insulin Market, by Drugs, 2017-2030 (US$ Bn)
TABLE 21 Canada Human Insulin Market, by Delivery Devices, 2017-2030 (US$ Bn)
TABLE 22 Canada Human Insulin Market, by Brand, 2017-2030 (US$ Bn)
TABLE 23 Europe Human Insulin Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 24 Europe Human Insulin Market, by Drugs, 2017-2030 (US$ Bn)
TABLE 25 Europe Human Insulin Market, by Delivery Devices, 2017-2030 (US$ Bn)
TABLE 26 Europe Human Insulin Market, by Brand, 2017-2030 (US$ Bn)
TABLE 27 Europe Human Insulin Market, by Country, 2017-2030 (US$ Bn)
TABLE 28 Germany Human Insulin Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 29 Germany Human Insulin Market, by Drugs, 2017-2030 (US$ Bn)
TABLE 30 Germany Human Insulin Market, by Delivery Devices, 2017-2030 (US$ Bn)
TABLE 31 Germany Human Insulin Market, by Brand, 2017-2030 (US$ Bn)
TABLE 32 France Human Insulin Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 33 France Human Insulin Market, by Drugs, 2017-2030 (US$ Bn)
TABLE 34 France Human Insulin Market, by Delivery Devices, 2017-2030 (US$ Bn)
TABLE 35 France Human Insulin Market, by Brand, 2017-2030 (US$ Bn)
TABLE 36 UK Human Insulin Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 37 UK Human Insulin Market, by Drugs, 2017-2030 (US$ Bn)
TABLE 38 UK Human Insulin Market, by Delivery Devices, 2017-2030 (US$ Bn)
TABLE 39 UK Human Insulin Market, by Brand, 2017-2030 (US$ Bn)
TABLE 40 Italy Human Insulin Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 41 Italy Human Insulin Market, by Drugs, 2017-2030 (US$ Bn)
TABLE 42 Italy Human Insulin Market, by Delivery Devices, 2017-2030 (US$ Bn)
TABLE 43 Italy Human Insulin Market, by Brand, 2017-2030 (US$ Bn)
TABLE 44 Spain Human Insulin Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 45 Spain Human Insulin Market, by Drugs, 2017-2030 (US$ Bn)
TABLE 46 Spain Human Insulin Market, by Delivery Devices, 2017-2030 (US$ Bn)
TABLE 47 Spain Human Insulin Market, by Brand, 2017-2030 (US$ Bn)
TABLE 48 Rest of Europe Human Insulin Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 49 Rest of Europe Human Insulin Market, by Drugs, 2017-2030 (US$ Bn)
TABLE 50 Rest of Europe Human Insulin Market, by Delivery Devices, 2017-2030 (US$ Bn)
TABLE 51 Rest of Europe Human Insulin Market, by Brand, 2017-2030 (US$ Bn)
TABLE 52 Asia Pacific Human Insulin Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 53 Asia Pacific Human Insulin Market, by Drugs, 2017-2030 (US$ Bn)
TABLE 54 Asia Pacific Human Insulin Market, by Delivery Devices, 2017-2030 (US$ Bn)
TABLE 55 Asia Pacific Human Insulin Market, by Brand, 2017-2030 (US$ Bn)
TABLE 56 Asia Pacific Human Insulin Market, by Country, 2017-2030 (US$ Bn)
TABLE 57 China Human Insulin Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 58 China Human Insulin Market, by Drugs, 2017-2030 (US$ Bn)
TABLE 59 China Human Insulin Market, by Delivery Devices, 2017-2030 (US$ Bn)
TABLE 60 China Human Insulin Market, by Brand, 2017-2030 (US$ Bn)
TABLE 61 Japan Human Insulin Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 62 Japan Human Insulin Market, by Drugs, 2017-2030 (US$ Bn)
TABLE 63 Japan Human Insulin Market, by Delivery Devices, 2017-2030 (US$ Bn)
TABLE 64 Japan Human Insulin Market, by Brand, 2017-2030 (US$ Bn)
TABLE 65 India Human Insulin Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 66 India Human Insulin Market, by Drugs, 2017-2030 (US$ Bn)
TABLE 67 India Human Insulin Market, by Delivery Devices, 2017-2030 (US$ Bn)
TABLE 68 India Human Insulin Market, by Brand, 2017-2030 (US$ Bn)
TABLE 69 South Korea Human Insulin Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 70 South Korea Human Insulin Market, by Drugs, 2017-2030 (US$ Bn)
TABLE 71 South Korea Human Insulin Market, by Delivery Devices, 2017-2030 (US$ Bn)
TABLE 72 South Korea Human Insulin Market, by Brand, 2017-2030 (US$ Bn)
TABLE 73 South East Asia Human Insulin Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 74 South East Asia Human Insulin Market, by Drugs, 2017-2030 (US$ Bn)
TABLE 75 South East Asia Human Insulin Market, by Delivery Devices, 2017-2030 (US$ Bn)
TABLE 76 South East Asia Human Insulin Market, by Brand, 2017-2030 (US$ Bn)
TABLE 77 Rest of Asia Pacific Human Insulin Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 78 Rest of Asia Pacific Human Insulin Market, by Drugs, 2017-2030 (US$ Bn)
TABLE 79 Rest of Asia Pacific Human Insulin Market, by Delivery Devices, 2017-2030 (US$ Bn)
TABLE 80 Rest of Asia Pacific Human Insulin Market, by Brand, 2017-2030 (US$ Bn)
TABLE 81 Latin America Human Insulin Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 82 Latin America Human Insulin Market, by Drugs, 2017-2030 (US$ Bn)
TABLE 83 Latin America Human Insulin Market, by Delivery Devices, 2017-2030 (US$ Bn)
TABLE 84 Latin America Human Insulin Market, by Brand, 2017-2030 (US$ Bn)
TABLE 85 Latin America Human Insulin Market, by Country, 2017-2030 (US$ Bn)
TABLE 86 Brazil Human Insulin Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 87 Brazil Human Insulin Market, by Drugs, 2017-2030 (US$ Bn)
TABLE 88 Brazil Human Insulin Market, by Delivery Devices, 2017-2030 (US$ Bn)
TABLE 89 Brazil Human Insulin Market, by Brand, 2017-2030 (US$ Bn)
TABLE 90 Mexico Human Insulin Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 91 Mexico Human Insulin Market, by Drugs, 2017-2030 (US$ Bn)
TABLE 92 Mexico Human Insulin Market, by Delivery Devices, 2017-2030 (US$ Bn)
TABLE 93 Mexico Human Insulin Market, by Brand, 2017-2030 (US$ Bn)
TABLE 94 Rest of Latin America Human Insulin Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 95 Rest of Latin America Human Insulin Market, by Drugs, 2017-2030 (US$ Bn)
TABLE 96 Rest of Latin America Human Insulin Market, by Delivery Devices, 2017-2030 (US$ Bn)
TABLE 97 Rest of Latin America Human Insulin Market, by Brand, 2017-2030 (US$ Bn)
TABLE 98 Middle East and Africa Human Insulin Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 99 Middle East and Africa Human Insulin Market, by Drugs, 2017-2030 (US$ Bn)
TABLE 100 Middle East and Africa Human Insulin Market, by Delivery Devices, 2017-2030 (US$ Bn)
TABLE 101 Middle East and Africa Human Insulin Market, by Brand, 2017-2030 (US$ Bn)
TABLE 102 Middle East and Africa Human Insulin Market, by Country, 2017-2030 (US$ Bn)
TABLE 103 GCC Countries Human Insulin Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 104 GCC Countries Human Insulin Market, by Drugs, 2017-2030 (US$ Bn)
TABLE 105 GCC Countries Human Insulin Market, by Delivery Devices, 2017-2030 (US$ Bn)
TABLE 106 GCC Countries Human Insulin Market, by Brand, 2017-2030 (US$ Bn)
TABLE 107 South Africa Human Insulin Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 108 South Africa Human Insulin Market, by Drugs, 2017-2030 (US$ Bn)
TABLE 109 South Africa Human Insulin Market, by Delivery Devices, 2017-2030 (US$ Bn)
TABLE 110 South Africa Human Insulin Market, by Brand, 2017-2030 (US$ Bn)
TABLE 111 Rest of Middle East and Africa Human Insulin Market, by Product Type, 2017-2030 (US$ Bn)
TABLE 112 Rest of Middle East and Africa Human Insulin Market, by Drugs, 2017-2030 (US$ Bn)
TABLE 113 Rest of Middle East and Africa Human Insulin Market, by Delivery Devices, 2017-2030 (US$ Bn)
TABLE 114 Rest of Middle East and Africa Human Insulin Market, by Brand, 2017-2030 (US$ Bn)